-transparent.png){kind=logo}
Previous studies using a highly sensitive 32P-postlabeling assay for the analysis of carcinogen/mutagen-induced DNA damage have shown the presence of tobacco smoking-related DNA adducts in human placenta (Everson, R.B., Randerath, E., Santella, R.M., Cefalo, R.C., Avitts, T. A., and Randerath, K., Science (Wash. DC), 231: 54-57, 1986). The occurrence of such adducts in smokers' bronchus and larynx is reported here. Since the chemical nature of these adducts could not be characterized by direct methods due to the extremely low levels of individual adducts (less than 0.03 fmol per microgram DNA), we have sought an experimental animal model for studying the formation of tobacco-related DNA adducts. Because cigarette smoke condensate is known to initiate tumors in mouse skin, ICR mice were treated topically with cigarette tar equivalent to 1.5, 3, 6, and 9 cigarettes for 0.4, 3, 5, and 7 days, respectively, and skin DNA was isolated 1 day after the last treatment. When DNA from exposed mice was analyzed by the 32P-postlabeling assay, 12 distinct 32P-labeled DNA adduct spots, as well as a diagonal radioactive zone, which presumably reflected the presence of incompletely resolved adducts, were noted on polyethyleneimine-cellulose TLC fingerprints. One derivative in particular (adduct 1) was seen to increase rapidly during the early treatment phase and also to persist to 8 days after treatment. The prominent adduct 1 was observed in the same location on the fingerprints of DNA samples from smokers. Cochromatography experiments suggested identity of human and mouse DNA adduct 1. Similarly, several other human and mouse adducts (adducts 3, 5, 6, and 9) appeared identical, and the diagonal radioactive zone was also present on DNA adduct maps from smokers. While absolute levels of individual human adducts were too low to be accurately quantitated, semiquantitative estimation of total tobacco-related aromatic DNA adducts in the human specimens gave values of 1 adduct in (1.7-2.9) X 10(7) nucleotides (0.10-0.18 fmol per micrograms DNA), with adduct 1 constituting 8.5-14% of the total. On the basis of these results, it appears now feasible to determine the chemical origin of smoking-induced DNA adducts in human tissues by preparation of authentic 32P-labeled reference adducts from animals treated with characterized subfractions of cigarette tar, 32P-postlabeling, and cochromatography of 32P-labeled human and animal adducts.
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
January 1993,
IARC scientific publications,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
July 1992,
Mutation research,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
May 1993,
Annals of the New York Academy of Sciences,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
January 1993,
IARC scientific publications,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
November 2004,
American journal of respiratory cell and molecular biology,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
May 1979,
Nature,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
January 1980,
Nature,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
October 1993,
Environmental health perspectives,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
July 1992,
Mutation research,
E Randerath, and
T A Avitts, and
M V Reddy, and
R H Miller, and
R B Everson, and
K Randerath
October 2011,
International journal of oncology,
